BEGIN:VCALENDAR
PRODID:-//eluceo/ical//2.0/EN
VERSION:2.0
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:2023fe34-22da-4170-9473-00513696e7a5
DTSTAMP:20261028T114046Z
SUMMARY:Nanostructured Metallic Complexes as Antitumoral Selective Agents
DESCRIPTION:<p style="text-align: left\;">PhD Student<strong>:&nbsp\;Roger 
 Gómez Herrera</strong></p>\n<p style="text-align: left\;"><strong>In pers
 on Event - Register <a href="https://forms.office.com/e/Y7rkLETrSC">HERE&n
 bsp\;</a>to attend</strong></p>\n<p><span style="color: #333333\;">Directo
 rs:<strong>&nbsp\;CSIC Research Prof. Daniel Ruiz Molina\, <a href="/en/na
 nostructured-functional-materials-group">Nanostructured Functional Materia
 ls</a>&nbsp\;</strong>Group Leader and<strong> Dr Fernando Novio\, </stron
 g>Associate Professor UAB.</span></p>\n<p style="text-align: justify\;"><s
 trong>Short Abstract:</strong></p>\n<p>Glioblastoma multiforme (GBM) is th
 e most aggressive primary brain tumour in adults. The current clinical sta
 ndard treatment\, established back in 2005\, includes surgical resection f
 ollowed by radiotherapy and temozolomide chemotherapy. Still\, GBM present
 s a median survival rate of less than two years and less than 6% five-year
  survival. This situation underscores the need to develop better therapeut
 ic agents. Pt compounds\, like cisplatin\, remain among the most potent an
 ticancer agents. However\, these drugs encounter obstacles in GBM due to b
 lood–brain barrier permeability\, systemic toxicities\, and resistance.<
 /p>\n<p>This Thesis develops on Pt-based drugs that address these barriers
  by exploring multi-target nanotherapies that improve tumour selectivity a
 nd targeting\, minimize systemic exposure\, while exploiting local therape
 utic windows. In these lines we investigate combination therapies\, and bi
 oinspired biomaterials as strategies to overcome these limitations. More s
 pecifically\, this Thesis focuses on four research lines whose novelty var
 ies as described next:</p>\n<p><strong>First</strong>\, Pt(IV) catechol-ba
 sed coordination nanoparticles (CNP) formed by oxidative polymerization of
  a Pt(IV) prodrug monomer (<strong>PtBC</strong>). This platform yields me
 lanin-like nanoparticles (NPs)\, a Trojan-horse approach for brain disease
 s\, with pH and redox-sensitive Pt(IV) release.</p>\n<p><strong>Second</st
 rong>\, squaraine (SQ)-based Pt(II) supramolecular NPs combining photoacti
 vated chemotherapy (PACT) and photodynamic (PDT) prospects of SQs. Accordi
 ng with the experimental results\, PACT was discarded while interesting PD
 T effects were found on SQ supramolecular NPs without Pt.</p>\n<p><strong>
 Third</strong>\, a bi-functional core-shell NP was designed with a superpa
 ramagnetic iron-oxide (SPION) core and a zirconium-based CNP shell bearing
  9\,10-diphenylanthracene moieties. The shell is capable to store singlet 
 oxygen under ultraviolet irradiation and release it on demand via magnetic
  hyperthermia (MHT) generated by the SPION core. <em>In vitro </em>studies
  on GL261 murine GBM model display a cooperative heat and reactive oxygen 
 species (ROS) cytotoxicity effect. <em>In vivo</em>&nbsp\;experiments demo
 nstrated the core-shell NP to be highly specific and sensitive to traverse
  relaxation weighted (<em>T2w</em>) magnetic resonance imaging. Unexpected
 ly\, the platform demonstrated as selective contrast agent for bladder at 
 very low concentrations\, far from the GBM target. On this research a seco
 nd NP platform based the CNP shell itself was developed and displayed exce
 llent cytotoxic effect on GL261 murine GBM model under MHT stimulus.</p>\n
 <p><strong>Fourth</strong>\, based on the <strong>PtBC</strong>&nbsp\;mono
 mer developed in the first approach\, we developed bioinspired catechol-ba
 sed Pt(IV) free-standing membranes (FSMs) as conformable\, wet‑adhesive 
 patches for insertion into resection cavities. This FSMs are formed by oxi
 dative co‑polymerization between a <strong>PtBC</strong>&nbsp\;monomer a
 nd an amine co-monomer to yield malleable membranes that release Pt locall
 y. Physicochemical characterisation\, controlled-release assays and <em>in
  vitro</em> cytotoxicity against GBM lines demonstrated the FSM’s potent
 ial as a post-surgical local therapy with plausible ROS synergistic effect
 s.</p>\n<p style="text-align: justify\;">All in all\, this Thesis provides
  proof-of-concepts for multimodal treatments\, exploiting complementary me
 chanisms (DNA damage\, oxidative stress\, hyperthermia and sustained local
  delivery) to increase tumour selectivity and reduce systemic toxicity</p>
 \n<p style="text-align: justify\;">&nbsp\;</p>\n<p style="text-align: just
 ify\;">&nbsp\;</p>
DTSTART:20251219T110000
DTEND:20251219T225959
LOCATION:ICN2 Seminar Room\, Campus UAB
CATEGORIES:ICN2 Theses Defence
END:VEVENT
END:VCALENDAR
